One challenge to advancing Alzheimer’s disease treatments is that many patients have mixed brain pathologies, meaning more than one disease process is affecting the brain. This can complicate diagnosis, clinical trial design and treatment development because a therapy targeting only one disease process may be less effective if another is…
By: Grace Huff Dawn Bowers, Ph.D., ABPP-CN A recent study highlights a potential link between selective serotonin reuptake inhibitors (SSRIs), a widely prescribed class of antidepressants, and increased apathy levels in individuals with Parkinson’s disease (PD). Apathy, a non-motor symptom that affects motivation, emotional engagement, and goal-directed behavior, is a…
By: Grace Huff The holiday season is often regarded as a time for joy, togetherness, and tradition. For many families, the rituals of decorating, cooking, and celebrating offer a sense of continuity and connection. However, for seniors living with cognitive impairment or Alzheimer’s disease, the holidays can present both emotional…
Dr. Sara Burke to co-lead UF’s Center for Cognitive Aging and Memory Clinical Translational Research.
Clinicians at the Norman Fixel Institute for Neurological Diseases at UF Health explored the differences a person's sex makes when it comes to DLB diagnosis and management.
Team at the University of Florida receives renewal as a Research Center of Excellence by the Lewy Body Dementia Association for their commitment and care for Lewy Body dementias.
Under new grant, a research team co-led by Dr. Malú Gámez Tansey will investigate possible links between the immune system and neurodegeneration in frontotemporal dementia.
Dr. Shannon Chiu awarded five-year grant from NIA to investigate changes in LBD using diffusion-weighted MRI and task-based EEG.
The Harry T. Mangurian Jr. Foundation supported grants for two Lewy body dementia pilot studies.
